Greenwich LifeSciences Short Interest Ratio and Short Volume

+1.81 (+5.31 %)
(As of 05/5/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume127,753 shs
Average Volume563,938 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Short Interest

Greenwich LifeSciences (NASDAQ:GLSI) Short Interest Data

Current Short Volume317,500 shares
Previous Short Volume191,900 shares
Change Vs. Previous Month+65.45%
Dollar Volume Sold Short$11.23 million
Short Interest Ratio / Days to Cover0.5
Last Record DateApril, 15 2021
Float Size2,380,000 shares
Short Percent of Float13.34%
Today's Trading Volume127,753 shares
Average Trading Volume563,938 shares
Today's Volume Vs. Average-77.35%

Short Interest Over Time

Greenwich LifeSciences (NASDAQ:GLSI) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/2021317,500 shares $11.23 million +65.5%13.3%0.5$35.36
3/31/2021191,900 shares $6.31 million -21.3%11.4%0.3$32.90
3/15/2021243,900 shares $7.10 million +218.8%14.4%0.5$29.12
2/26/202176,500 shares $2.50 million +58.4%4.8%0.1$32.63
2/12/202148,300 shares $1.93 million +20.5%3.1%0.1$39.98
1/29/202140,100 shares $1.37 million -20.9%2.5%0$34.20
1/15/202150,700 shares $1.82 million No Change3.2%0.1$35.90

Greenwich LifeSciences (NASDAQ:GLSI) Short Interest FAQ

speech bubbles
speech bubbles

What is Greenwich LifeSciences' current short interest?

Short interest is the volume of Greenwich LifeSciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 317,500 shares of GLSI short. 13.34% of Greenwich LifeSciences' shares are currently sold short. View details.

What is a good short interest percentage for Greenwich LifeSciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.34% of Greenwich LifeSciences' floating shares are currently sold short.

Is Greenwich LifeSciences' short interest increasing or decreasing?

Greenwich LifeSciences saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 317,500 shares, an increase of 65.5% from the previous total of 191,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Greenwich LifeSciences' float size?

Greenwich LifeSciences currently has issued a total of 0 shares. Some of Greenwich LifeSciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Greenwich LifeSciences currently has a public float of 2,380,000 shares.

How does Greenwich LifeSciences' short interest compare to its competitors?

13.34% of Greenwich LifeSciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Greenwich LifeSciences: Affymax, Inc. (0.00%), ARYx Therapeutics, Inc. (0.00%), China Botanic Pharmaceutical Inc. (0.00%), China Dongsheng International, Inc. (0.00%), Harbor Diversified, Inc. (0.00%), Interpharm Holdings, Inc. (0.00%), Myrexis, Inc. (0.00%), Nanobac Pharmaceuticals, Incorporated (0.00%), Sunwin Stevia International, Inc. (0.00%), and Sycamore Entertainment Group, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.85 billion), Aon plc ($5.61 billion), Charter Communications, Inc. ($5.44 billion), Snap Inc. ($3.49 billion), Airbnb, Inc. ($3.35 billion), Peloton Interactive, Inc. ($2.53 billion), ViacomCBS Inc. ($2.48 billion), Expedia Group, Inc. ($2.39 billion), The Kroger Co. ($2.26 billion), and Nuance Communications, Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Greenwich LifeSciences stock?

Short selling GLSI is an investing strategy that aims to generate trading profit from Greenwich LifeSciences as its price is falling. Greenwich LifeSciences' stock is trading up $1.81 today. To short Greenwich LifeSciences stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Greenwich LifeSciences will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Greenwich LifeSciences?

A short squeeze for Greenwich LifeSciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GLSI, which in turn drives the price of the stock up even further.

How often is Greenwich LifeSciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLSI, twice per month. The most recent reporting period available is April, 15 2021.

This page was last updated on 5/6/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.